Fred Hutch study: Mangling RNA may extend use of immunotherapy drugs

Fred Hutch study: Mangling RNA may extend use of immunotherapy drugs

Fred Hutch computer biologist Robert Bradley. (Fred Hutch photo) Experimental compounds that alter RNA increase the effectiveness of immunotherapeutic drugs against cancer cells and could potentially extend their use to more patients, suggests a study in mice at the Fred Hutchinson Cancer Research Center. Immunotherapeutic agents called checkpoint inhibitors, which induce the immune system to … Read more

New high-tech lab at Fred Hutch creates 3D maps of proteins to aid therapeutics and vaccine research

New high-tech lab at Fred Hutch creates 3D maps of proteins to aid therapeutics and vaccine research

Assistant Professor Melody Campbell prepares a sample in the Cryo-EM Laboratory for Shared Resources at the Fred Hutchinson Cancer Research Center in Seattle. (Fred Hutch photo) Dr. Melody Campbell was an undergraduate student when she first noticed the beauty and power of cryogenic electron microscopy (cryo-EM), a technique that uses extreme temperatures and an electron … Read more